Thepresenceofkidneydiseasemay alterthe pharmacokinetic handling ofmamy drugs.
WhichoneofthefoLowinq pharmacokinetic parameters ismostuikely to occur as a resut of chronic
kidney disease?
Alteredvolumeof distribution
Increaseddrugabsorption
Increasedproteinbindina
Liver metabolism ofdmuas
Reducedbioavailabiuitv immediately after intravenousdruqinjection
@1MINNDOCRINE
